News EUSA Pharma's Fotivda approved in EU for kidney cancer UK pharma gets licence for second cancer drug
News BMS shares fall after latest Opdivo disappointment BMS waiting for overall survival data of Opdivo and Yervoy in kidney cancer
News EUSA Pharma looks to further in-licensing to build growth Specialist company EUSA Pharma is looking for new medicines to develop after getting two cancer drugs recommended by European regulators this year.
News Ipsen/Exelixis' drug approved in EU for kidney cancer Cabometyx secures new indication in renal cell carcinoma.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
